Purchase Order 75N92E24P00142
- Not listed
- The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a $15,000 purchase order to Illumina, Inc. to provide DRAGEN CS LVL 1 LICENSE THROUGHPUT OF 100,000GB under contract number E21C6L5011010032. The one-year contract, which runs from July 2025 through July 2026, calls for Illumina to deliver genomic sequencing software licensing and throughput on a firm fixed price basis, to be billed quarterly in arrears. As the prime...
- This is a firm fixed-price purchase order awarded by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The $15,575 contract is for the delivery of Illumina's proprietary sequencing systems, reagents, and related products and services to support the Institute's genomic research and diagnostics activities. This award is not associated with any...
- This firm fixed-price delivery order was awarded by the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health (NIH), to Illumina, Inc. for $499,993.60. The award is not associated with a set-aside program. Illumina is providing a range of sequencing systems, reagents, consumables, and related services to support genomic sequencing and analysis for NHGRI research and diagnostic applications. Illumina has previously received prime federal contracts and...
- This is a federal contract award to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The award, valued at $10,331.78, is a delivery order placed under a larger federal contract vehicle. The award is for Illumina to provide sequencing systems, reagents, and related services to support genomic sequencing and analysis for the National Human Genome Research Institute, which is part of the National Institutes of Health (NIH), a civilian agency. The...
- This is a firm fixed price purchase order awarded by the National Human Genome Research Institute (NHGRI), which is part of the National Institutes of Health (NIH), a civilian agency. The contract, valued at $770,306.04, was awarded to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract does not have a set-aside designation. Under this contract, Illumina will provide a range of goods and services to support genomic sequencing...
- The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a firm fixed price purchase order valued at twenty thousand two hundred ninety-eight dollars and ninety-nine cents ($20,298.99) to Illumina, Inc. to provide a one-year license for the DRAGEN CS Level 1 throughput of one hundred thousand gigabytes. The license will be delivered under a thirteen point six month period running from May seventh, two thousand twenty-one through...
- This federal contract award, valued at $10,331.78, was issued by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH), to Illumina, Inc. The contract is a delivery order for the provision of Illumina's proprietary sequencing systems, reagents, and consumables to support genomic sequencing and analysis. This order is part of a larger Indefinite Delivery Contract worth up to $3.3 million that Illumina holds with the Department of the Navy...
- This firm fixed-price delivery order was awarded by the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health (NIH), to Illumina, Inc. for $17,149.00. The award is not associated with a set-aside program. Illumina, a manufacturer of sequencing and genomic analysis instruments and reagents, has previously received prime federal contracts and subcontracts from agencies like the NIH, CDC, USDA, and VA to provide sequencing platforms, consumables, and services...
- This firm fixed-price delivery order was awarded to Illumina, Inc. by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH), a civilian agency. The $9,909.50 contract is not set-aside and provides for the delivery of Illumina's proprietary sequencing systems, reagents, and associated services to support genomic sequencing and analysis research at NHGRI. Illumina has a history of providing similar goods and services to other federal...
- This is a $127,989.57 firm fixed-price delivery order awarded by the National Human Genome Research Institute, a civilian agency within the National Institutes of Health, to Illumina, Inc., a biotechnology company specializing in genetic sequencing technologies. The contract has a period of performance ending on July 30, 2026. Illumina, a for-profit manufacturer, has been awarded multiple federal contracts and blanket purchase agreements to provide a range of genomic sequencing platforms,...
This federal contract award, valued at $15,000.00, was issued by the National Human Genome Research Institute (NHGRI) to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The contract is for a DRAGEN CS Level 1 License with a throughput of 100,000GB, with a period of performance from July 25, 2024 to July 24, 2025. The contract is a firm fixed price purchase order and does not have a set-aside designation. Illumina has previously received prime federal contracts and grants from agencies such as the National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), and Department of Agriculture (USDA) to provide sequencing systems, reagents, and bioinformatics products to support genomic research and diagnostics. This award appears to be a continuation of Illumina's work in providing core genomic sequencing capabilities to the National Human Genome Research Institute, which is a component of the NIH focused on advancing genomic science.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00003 | Other Administrative Action | $0 | 4/7/25 | |
| P00002 | Other Administrative Action | $0 | 4/1/25 | |
| P00001 | Other Administrative Action | $0 | 6/18/24 | |
| Not listed | Not listed | $15.0k | 5/3/24 |